• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. OLYMPUS ESG-100, 100...120 V~,; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. OLYMPUS ESG-100, 100...120 V~,; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Model Number WB991046
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Bowel Perforation (2668)
Event Date 06/13/2022
Event Type  Injury  
Manufacturer Narrative
The literature described model number "esg-100, esg-300", and olympus selected "esg-100 (wb991046)" as a representative product.This event involves six related patient identifiers: (b)(6).This medwatch is for patient identifier (b)(6).The literature article is attached and doi: 10.1002/aid2.13344 is provided for additional information.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation or when additional information becomes available.
 
Event Description
Olympus reviewed the literature titled "risk factors for perforation during colorectal endoscopic submucosal dissection." endoscopic submucosal dissection (esd) achieves higher en bloc resection rates than endoscopic mucosal resection in early colorectal neoplasms.However, perforation occurs more frequently during esd.We aimed to identify the risk factors for perforation during colorectal esd.A total of 161 patients treated with colorectal esd at a tertiary center between (b)(6) 2014 and (b)(6) 2019 were enrolled in this retrospective study.Perforation was defined as a deep defect of the muscularis propria, with or without direct contact with connective tissue outside the colon.Clinical risk factors for perforation during esd, including age, sex, tumor morphology, tumor size, tumor location, procedure time, en bloc resection rate, histology, and submucosal fibrosis, were analyzed.The mean size of the esd specimens was 38.2 ± 24.6 mm.The overall en bloc resection rate was 98.1%.Perforations occurred during esd in 31 out of 161 patients (19.3%).All perforations were successfully treated with endoscopic closure using the hemoclips and nonsurgical management.Emergency surgery was not required in our patients.On multivariate analysis, severe submucosal fibrosis (odds ratio [or] 3.06; 95% confidence interval [ci] 1.23-7.59; p =.016) and location in the right colon (or 4.54; 95% ci 1.31-15.79; p =.017) were independent risk factors.Perforation during colorectal esd occurred in 31 patients (19.3%), but all patients had a good outcome without surgery.Submucosal fibrosis and its location are risk factors for perforation during esd.Type of adverse events/number of patients: perforation - 31 patients minor bleeding - number of patients not specified.All perforations that occurred during colorectal esd were successfully managed with endoscopic closure without rescue surgery.Most cases showed minor bleeding, which were successfully managed with immediate hemostasis by hemoclipping and coagulation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OLYMPUS ESG-100, 100...120 V~,
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA   961-8061
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18685061
MDR Text Key335293866
Report Number3002808148-2024-01282
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/12/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberWB991046
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DISPOSABLE DISTAL ATTACHMENT (D-201-15004); EVIS LUCERA ELITE COLONOVIDEOSCOPE (PCF-H290ZI); EVIS LUSERA COLONOVIDEOSCOPE (PCF-Q260AZI); SINGLE USE ELECTROSURGICAL KNIFE (KD-655); SINGLE USE INJECTOR (NM-610U-0423)
Patient Outcome(s) Required Intervention;
-
-